Biggest News Aggregation in the World
📰 Product Testing News

Page 38 - Product Testing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Product Testing. Real-time updates on events, politics, business and more.

Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors Passage BioFebruary 19, 2021 GMT PHILADELPHIA, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced the appointment of Maxine Gowen, Ph.D., to its board of directors, effectiv...
University Of Pennsylvania United States Wharton School Gwen Fisher Bruce Goldsmith Maxine Gowen
Source: apnews.com

Sumitovant Biopharma Announces Publication in the New England Journal of Medicine of Myovant ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sumitovant Biopharma Announces Publication in the New England Journal of Medicine of Myovant ... Sumitovant BiopharmaFebruary 18, 2021 GMT New York, London, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Sumitovant Biopharma Ltd., a majority shareholder of Myovant Sciences (NYSE: MYOV), announced today that the New England Journal of Medicine published Myovant Sciences’ Phase 3 LIBERTY 1 and LIBERTY 2 studies of...
New York United States City Of United Kingdom Sumitomo Dainippon Pharma Sumitovant Biopharma
Source: apnews.com

Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis

Press release content from Business Wire. The AP news staff was not involved in its creation. Kyowa Kirin Announces Positive Phase 2 Results for KHK4083 in Patients with Moderate to Severe Atopic Dermatitis February 18, 2021 GMT TOKYO--(BUSINESS WIRE)--Feb 18, 2021-- For Medical Media only. Kyowa Kirin Co., Ltd. (TSE: 4151, President and CEO: Masashi Miyamoto, “Kyowa Kirin”), a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in life s...
United States Masashi Miyamoto Stacey Minton Emma Guttman Yassky Asia Pacific Tomomasa Yagisawa
Source: apnews.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Angle PLC Announces Parsortix-Harvested CTCs Uncover Novel Biomarker

Press release content from Accesswire. The AP news staff was not involved in its creation. Angle PLC Announces Parsortix-Harvested CTCs Uncover Novel Biomarker February 18, 2021 GMT Parsortix system able to harvest difficult-to-detect mesenchymal CTCs Metastatic biomarker Cyr61 found by researchers in 40% of breast cancer CTCs may be a novel therapeutic target in treating drug-resistant breast cancers GUILDFORD, SURREY / ACCESSWIRE / February 18, 2021 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-...
Nordrhein Westfalen United States Western Australia City Of United Kingdom Carl Holmes
Source: apnews.com

Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key ... Myriad Genetics, Inc.February 18, 2021 GMT SALT LAKE CITY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced several new technology and healthcare leaders who recently joined the company as well as key promotions to drive...
United States White House District Of Columbia Jared Maxwell Kevinr Haas Jackie Zou
Source: apnews.com

Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference ... Caladrius Biosciences, Inc.February 18, 2021 GMT BASKING RIDGE, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse diseas...
John Menditto Christiana Pascale Caladrius Biosciences Caladrius Biosciences Inc Corporate Communications Drug Administration
Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science